Skip to main content
Clinical Trials/NCT06899620
NCT06899620CompletedNot Applicable

Weizmannia Coagulans BC179 Alleviates Post-Alcohol Discomfort May Via Taurine-Related Metabolism and Antioxidant Regulation: A Randomized, Double-Blind,Placebo-Controlled Trial

Wecare Probiotics Co., Ltd.2 sites in 1 country60 target enrollmentStarted: July 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
2
Primary Endpoint
Effects of BC179 on alcohol metabolism

Study Overview

Brief Summary

To assess the effectiveness and safety of probiotic strain BC179 in reducing alcohol absorption in the gut, thereby lowering health risks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Inclusion Criteria:
  • •Participants must be aged between 18 and 65 years.
  • •They should have a documented history of long-term alcohol consumption, defined as consuming at least 20 grams of ethanol per day for at least one year. This is calculated using the formula: volume (mL) × alcohol content (%) × 0.
  • •They must provide written informed consent and be willing to comply with the study procedures.

Exclusion Criteria

  • •History of chronic liver, gastrointestinal, or systemic metabolic disorders.
  • •Use of products with similar functions to the investigational formulation within the past two weeks.
  • •Use of antibiotics, laxatives, or dietary supplements within the past four weeks.
  • •Documented history of hypertension or diabetes.
  • •Severe allergies or immune deficiencies.
  • •Pregnancy, lactation, or planning pregnancy without effective contraception during the study period.

Arms & Interventions

Probiotic group

Experimental

10B CFU/Sachet/Day BC179 ; Storage: Store in cool and dry place without sun exposure

Intervention: Probiotic group (Dietary Supplement)

Placebo group

Placebo Comparator

Dextrin one Sachet/Day; Storage: Store in cool and dry place without sun exposure

Intervention: Placebo group (Dietary Supplement)

Outcomes

Primary Outcomes

Effects of BC179 on alcohol metabolism

Time Frame: 60 days

The impact of BC179 on alcohol metabolism is assessed by monitoring blood alcohol concentration (BAC) and related enzyme activities, such as alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

BC179 Relieves Discomfort After Drinking | Clinical Trial